Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Francesca Corra joins the Kennedy Institute as Leverhulme artist in residence.

Francesca Corra has joined the Arthritis Research UK Centre for OA Pathogenesis at the Kennedy Institute of Rheumatology as artist in residence. The position is funded by the Leverhulme Trust as part of a scheme to promote creative collaboration between artists and UK universities or museums.

During her time at the Centre, Francesca will explore the disease process of hand arthritis and how patients, clinicians and researchers interact with the condition. She will produce a series of works focused on "arthritic diseases of the hand" and the "healing hands" of the physicians, therapists and surgeons who treat them.

Francesca's residency will culminate in a public workshop and exhibition of hand portraits. Each portrait will be accompanied by a short description about the person and their relationship with arthritis. Initially, the work will be exhibited at the Nuffield Orthopaedic Hospital, Oxford. After this time, the series will be displayed at the Kennedy Institute, where it will be visible to scientists, administrative staff and visitors as a reminder of why research into osteoarthritis and other types of arthritis is important.

Francesca is a London-based artist who specialises in drawing and is primarily interested in the intersection between art and science. Her work is focused on exploring human anatomy and pathology, which she manipulates in her meticulous renditions. Alongside her artwork, Francesca also practices as a freelance Medical Artist creating high-quality custom medical and scientific illustrations for private commissions and publications.

Speaking of her new position, Francesca said, "I am thrilled to be involved with the OA Centre. Being here will give me the opportunity to explore a subject that has always fascinated me and will enable me to create a new body of work, which will hopefully benefit those that work and are associated with the Institute."

Directed by Professor Tonia Vincent, the OA Centre brings together researchers and clinicians with an interest in osteoarthritis from across Oxford and the UK. The Centre creates strong links between the laboratory and clinic and aims to identify pathological drivers of disease and develop new treatments or biomarkers.

The Leverhulme Trust was established by the Will of William Hesketh Lever, the founder of Lever Brothers. Since 1925 the Trust has provided grants and scholarships for research and education and is one of the largest all-subject providers of research funding in the UK.

Similar stories

The Kennedy Institute Student Symposium returns for its 5th year

A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Drug may boost vaccine responses in older adults

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.